CSP
RMD icon

Cary Street Partners’s ResMed RMD Stock Holding History

Cary Street Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39K Buy
200
+185
+1,233% +$38.3K ﹤0.01% 1053
2026
Q1 		$3.37K Buy
+15
New +$3.74K ﹤0.01% 978
2025
Q3 		– Sell
-20
Closed -$5.16K – 956
2025
Q2 		$5.16K Buy
20
+5
+33% +$1.19K ﹤0.01% 891
2025
Q1 		$3.36K Sell
15
-34
-69% -$7.94K ﹤0.01% 854
2024
Q4 		$11.2K Buy
+49
New +$11.8K ﹤0.01% 822

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Cary Street Partners's RMD Position: Q2 2026 in Review

Cary Street Partners increased its ResMed (RMD) stake by 1,233% in Q2 2026, buying an estimated $38.3K and bringing the position to 200 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Cary Street Partners first reported a position in RMD in Q4 2024 and has held it in 5 quarters since. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cary Street Partners held 200 shares of ResMed worth $39K as of Q2 2026.
  • Cary Street Partners bought 185 ResMed shares in Q2 2026, an estimated $38.3K.
  • ResMed made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #1053 holding.
  • Cary Street Partners first reported a position in ResMed in Q4 2024 and has held it in 5 quarters since.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.